The Promise of Low-Dose Aspirin on Longevity in the Geriatric Population: No Effect on Outcomes in the US and Australia Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 10/17/2018 https://www.nejm.org/doi/full/10.1056/NEJMoa1800722 Effect of Aspirin on Disability-free Survival in the Elderly ORIGINAL ARTICLE Effect of Aspirin on Disability-free Survival in the Healthy Elderly J.J. McNeil and Others […]
Search Results for 'Aspirin'
The Promise of Low-Dose Aspirin on Longevity in the Geriatric Population: No Effect on Outcomes in the US and Australia
Posted in Atherogenic Processes & Pathology, Cardiovascular Research, Coagulation Therapy and Internal Bleeding, Frontiers in Cardiology and Cardiovascular Disorders, HTN, inflammation independent of lipid levels, Pharmacotherapy of Cardiovascular Disease, Stroke on September 24, 2018| Leave a Comment »
Aspirin Advocate vs Skeptic: Any Common Ground? – Medscape
Posted in Uncategorized on November 3, 2014| Leave a Comment »
UPDATED on 7/17/2016 Aspirin Fails to Prevent Cardiovascular Events in High-Risk Patients Significant bleeding risk may outweigh any benefit Aspirin Fails to Prevent Cardiovascular Events in High-Risk Patients Aspirin Advocate vs Skeptic: Any Common Ground? Source: login.medscape.com See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY
Intracranial Vascular Stenosis: Comparison of Clinical Trials: Percutaneous Transluminal Angioplasty and Stenting (PTAS) vs. Clot-inhibiting Drugs: Aspirin and Clopidogrel (dual antiplatelet therapy) – more Strokes if Stenting
Posted in Atherogenic Processes & Pathology, Cardiac and Cardiovascular Surgical Procedures, Cerebrovascular and Neurodegenerative Diseases, Innovations in Neurophysiology & Neuropsychology, PCI on October 15, 2014| 2 Comments »
Intracranial Vascular Stenosis: Comparison of Clinical Trials: Percutaneous Transluminal Angioplasty and Stenting (PTAS) vs. Clot-inhibiting Drugs: Aspirin and Clopidogrel (dual antiplatelet therapy) – more Strokes if Stenting Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 8/5/2018 Clopidogrel plus aspirin bests aspirin alone for CV event reduction: Cochrane Source: JAMA, Published online July 26, 2018. doi:10.1001/jama.2018.9641 Curated […]
Platelet Endothelial Aggregation Receptor-1 (PEAR1) Gene to be most strongly associated with Dual Antiplatelet Therapy Response: Genetic Determinants of Variable Response to Aspirin (alone and in combination with Clopidogrel)
Posted in Atherogenic Processes & Pathology, Cardiac and Cardiovascular Surgical Procedures, Cardiovascular Pharmacogenomics, Cardiovascular Research, Cell Biology, Signaling & Cell Circuits, Chemical Genetics, Coagulation Therapy and Internal Bleeding, Computational Biology/Systems and Bioinformatics, FDA Regulatory Affairs, Frontiers in Cardiology and Cardiovascular Disorders, Genome Biology, Genomic Testing: Methodology for Diagnosis, HTN, Medical and Population Genetics, Origins of Cardiovascular Disease, PCI, Personalized and Precision Medicine & Genomic Research, Pharmacotherapy of Cardiovascular Disease, Stents & Tools, Valves & Tools, tagged Antiplatelet drug, Aspirin, Clopidogrel, Eukaryotic, genetics, myocardial infarction, Platelet on December 30, 2013| Leave a Comment »
Platelet Endothelial Aggregation Receptor-1 (PEAR1) Gene to be most strongly associated with Dual Antiplatelet Therapy Response: Genetic Determinants of Variable Response to Aspirin (alone and in combination with Clopidogrel) Reporter: Aviva Lev-Ari, PhD, RN 4 Genetic Variation in PEAR1 is Associated with Platelet Aggregation and Cardiovascular Outcomes Joshua P. Lewis1, Kathleen Ryan1, Jeffrey R. O’Connell1, Richard B. Horenstein1,Coleen M. Damcott1, Quince […]
Excerpt of 117 Followers of @AVIVA1950 (from the List of 359 Followers) by the Number of their Followers
Posted in on March 4, 2019|
Updated on 4/13/2019 Twitter Data of LPBI Group’s Founder’s Twitter handle @AVIVA1950 was updated On 2/24/2019 — Tweets 8,060 Following 1,412 Followers 359 Likes 2,752 On 4/13/2019 — Tweets 9,018 Following 1,461 Followers 390 Likes 3,654 In 48 days # Follower increases from 359 to 390 – Growth rate of 8% Three new “I” Followers […]
Aortic Stenosis (AS): Managed Surgically by Transcatheter Aortic Valve Replacement (TAVR) – Search Results for “TAVR” on NIH.GOV website, Top 16 pages
Posted in Aortic Valve: TAVR, TAVI vs Open Heart Surgery, Atherogenic Processes & Pathology, Cardiac and Cardiovascular Surgical Procedures, Congenital Heart DIsease, Frontiers in Cardiology and Cardiovascular Disorders, Medical Devices R&D and Inventions, Origins of Cardiovascular Disease, TAVI vs Open Heart Surgery, Valves & Tools on August 14, 2018| Leave a Comment »
Aortic Stenosis (AS): Managed Surgically by Transcatheter Aortic Valve Replacement (TAVR) – Search Results for “TAVR” on NIH.GOV website, Top 16 pages Reporter: Aviva Lev-Ari, PhD, RN UPDATED on 9/24/2018 Sapien 3, CoreValve Evolut R on Par for Aortic Stenosis Head-to-head trial also shows local, general anesthesia outcomes similar by Ashley Lyles, Staff Writer, MedPage Today September 23, […]
Single-Author Reporting on MedTech and Cardiac Medical Devices by Aviva Lev-Ari, PhD, RN
Posted in on August 6, 2018|
Single-Author Reporting on MedTech and Cardiac Medical Devices by Aviva Lev-Ari, PhD, RN On 8/13/2018 Reportings, N = 150 157r Comparison of four methods in diagnosing acute myocarditis: The diagnostic performance of native T1, T2, ECV to LLC Reporter: Aviva Lev-Ari, PhD, RN https://pharmaceuticalintelligence.com/2018/08/08/comparison-of-four-methods-in-diagnosing-acute-myocarditis-the-diagnostic-performance-of-native-t1-t2-ecv-to-llc/ 156r Left ventricular outflow tract (LVOT) obstruction (LVOTO): The Role […]
Advertisements
-
Recent Posts
- Pfizer buys out Array BioPharma for $11.4 Billion to beef up its oncology offerings June 17, 2019
- Tweets, Pictures and Retweets at 18th Annual Cancer Research Symposium – Machine Learning and Cancer, June 14, 2019, MIT by @pharma_BI and @AVIVA1950 for #KIsymposium PharmaceuticalIntelligence.com and Social Media June 16, 2019
- Featuring Computational and Systems Biology Program at Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute (SKI), The Dana Pe’er Lab June 16, 2019
- Can Elelphants Help Fight Cancer? June 16, 2019
- New ways to Heal Damage after a Heart Attack June 14, 2019
- Optimization of CRISPR Gene Editing with Gold Nanoparticles June 13, 2019
- Healing Powers of Fibrinogen June 13, 2019
- Breakthrough in Gene Editing CRISPR–Cas systems: First example of a fully programmable, RNA-guided integrase and lays the foundation for genomic manipulations that obviate the requirements for double-strand breaks and homology-directed repair. June 13, 2019
- Laboratory for Genomics Research (LGR) to be established by GSK ($67M investment in 5 years) at UC, Berkeley/UCSF to be lead by Prof. Jennifer Doudna focusing on immunology, oncology, and neuroscience disease-causing gene mutations and development of new technologies using CRISPR to accelerate new drug discovery June 13, 2019
- Alternative to CRISPR/Cas9 – CAST (CRISPR-associated transposase) – A New Gene-editing Approach for insertion of Large DNA Sequences into a Genome developed @BroadInstitute @MIT @Harvard June 11, 2019
Archives
Categories
Meta
-
2012pharmaceutical
-
Aashir Awan, Phd
-
Alan F. Kaul, PharmD., MS, MBA, FCCP
-
alexcrystal6
-
amnondanzig1724
-
anamikasarkar
-
apreconasia
-
aviralvatsa
-
David Orchard-Webb, PhD
-
danutdaagmailcom
-
Demet Sag, Ph.D., CRA, GCP
-
Dror Nir
-
evelinacohn
-
Gail S Thornton
-
Irina Robu
-
jdpmd
-
kellyperlman
-
Ed Kislauskis
-
larryhbern
-
lmulligan13gmailcom
-
marzankhan
-
megbaker58
-
pkandala
-
Rosalind Codrington, PhD
-
ritusaxena
-
Rick Mandahl
-
sjwilliamspa
-
stuartlpbi
-
Dr. Sudipta Saha
-
tildabarliya
-
zraviv06
-
zs22
-
Advertisements
